Drawing for JOSI

USPTO serial 99375391

JOSI

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
OGUNFEMI, RASHEEDAT
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with JOSI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $474*

Plus Government fees of $375

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
041Providing classes, seminars, workshops, and training for parents, instructors, and other individuals in the field of education for individuals with autism and other developmental disordersACTIVE—
042Software as a service (SAAS) services featuring software for the assessment, diagnosis and treatment of behavioral health conditions, such as autism spectrum disorders; Software as a service (SAAS) services featuring software for medical assessments and guiding healthcare providers' clinical decision-making using machine learning algorithms modeled after standard medical evaluation methodologies in the field of behavioral health; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the diagnosis and treatment of behavioral health conditions; Medical research in the field of autism; Medical research in the field of behavioral healthACTIVE—
044Remote monitoring of medical data for medical diagnosis and treatment; Managed health care services; Health care services, namely, diagnostic services, behavior analysis, occupational therapy, physical therapy, and speech therapy; Providing an internet website featuring news and information relating to diagnosis and treatment of autism; ADHD screening servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Apr 28, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 7, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 7, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 7, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 26, 2026DOCKASSIGNED TO EXAMINER—
Jan 25, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 4, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance